Skip to content

Neurotrophic Receptor Tyrosine Kinase (NTRK1, NTRK2, NTRK3) Mutation Analysis

Published: August 9, 2026Updated: August 16, 2026

This test checks for specific genetic changes (mutations) in the NTRK genes, which are involved in cell growth and development. These mutations can be linked to certain cancers or other rare conditions.

Quick summary

This test helps identify genetic variations that may influence cancer risk or response to targeted therapies.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
105596-1
Short code
NTRK1 & NTRK2 & NTRK3 targ mut anl Tiss
Synonyms
NTRK1 & NTRK2 & NTRK3 targ mut anl Tiss
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have a type of cancer (such as certain solid tumors) where NTRK gene mutations are known to play a role. It could also be used in research or for patients with rare genetic disorders linked to these genes.

What the Test Involves

A small sample of tissue (such as a tumor biopsy) or blood may be collected for testing. The test analyzes DNA to detect mutations in the NTRK1, NTRK2, or NTRK3 genes. Results help determine if targeted treatments could be effective.

What the Results Mean

If mutations are found, they may indicate a potential response to specific therapies designed to target these genetic changes. If no mutations are detected, it may help guide treatment decisions differently.

Common Uses in Clinical Care

This test is primarily used in oncology to guide treatment planning for cancers where NTRK mutations are clinically relevant, such as certain types of neuroendocrine tumors or sarcomas. It may also be part of broader genetic testing for inherited conditions.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

NTRK gene mutations can drive tumor growth in some cancers. Detecting these mutations helps clinicians select therapies that specifically inhibit these pathways, potentially improving outcomes. However, results should be interpreted alongside clinical findings and other diagnostic tests.

Short name

NTRK Gene Mutation Test

Frequently asked questions

What does a positive result mean?
A positive result means mutations in the NTRK genes were found in your sample. This may suggest that certain targeted therapies could be effective, but further discussion with your doctor is needed to explore treatment options.
How long does it take to get results?
Test results typically take several weeks to a few months, depending on the laboratory and complexity of the analysis. Your healthcare provider will contact you once results are available.
Are there any risks or side effects from this test?
There are usually no risks associated with tissue or blood sampling for this test. However, minor discomfort or bruising may occur at the sample collection site.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy